IGF-1 and IGF-1R in Breast Cancer
Author Information
Author(s): Al Sarakbi W, Chong YM, Williams SLJ, Sharma AK, Mokbel K
Primary Institution: Breast Unit St.George's Hospital and Medical School
Hypothesis
What is the relationship between mRNA expression levels of IGF-1 and various clinicopathological parameters in breast cancer?
Conclusion
The study found a significant association between IGF-1 mRNA expression and lymph node status in breast cancer patients.
Supporting Evidence
- All 31 patients had detectable levels of mRNA for both IGF-1 and IGF-1R.
- The median values of relative expression of IGF-1 mRNA were significantly different between tumor and adjacent non-cancerous tissue.
- A significant association was found between IGF-1 mRNA expression and lymph node status.
Takeaway
This study looked at how a specific protein related to growth, called IGF-1, behaves in breast cancer and found it can be linked to how many lymph nodes are affected.
Methodology
The study involved 31 breast cancer patients from whom tumor and adjacent non-cancerous tissue samples were collected and analyzed for IGF-1 and IGF-1R mRNA expression using RT-PCR.
Limitations
The small sample size may limit the generalizability of the findings.
Participant Demographics
The median age of participants was 69, with 7 patients below 50 and 6 pre-menopausal.
Statistical Information
P-Value
p = 0.0032
Confidence Interval
0.281–0.711 for IGF-1 in tumor; 0.338–0.874 for IGF-1 in ANCT
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website